Stephen Davis is CEO at ACADIA PHARMACEUTICALS INC (ACAD). They have made 26 open-market trades across 1 company since 2010, most recently 2024-08-19.
CIK 0001131146
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 26 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ACAD | SELL | 2024-08-19 | 2024-08-20 | $15.28 | $970K | +5.9% | +4.9% | +8.7% |
| ACAD | SELL | 2024-05-02 | 2024-05-03 | $16.94 | $387K | -11.8% | -10.9% | +10.7% |
| ACAD | SELL | 2024-04-08 | 2024-04-09 | $17.87 | $950K | -5.1% | -14.2% | -7.9% |
| ACAD | SELL | 2024-03-27 | 2024-03-27 | $17.90 | $634K | -0.3% | -8.2% | -14.3% |
| ACAD | SELL | 2024-02-26 | 2024-02-27 | $24.67 | $275K | -4.9% | -25.0% | -38.8% |
| ACAD | SELL | 2024-01-08 | 2024-01-09 | $29.96 | $224K | -9.5% | -16.3% | -42.0% |
| ACAD | SELL | 2023-10-06 | 2023-10-06 | $21.96 | $2.3M | +8.1% | +11.6% | +39.4% |
| ACAD | SELL · 10b5-1 | 2023-07-14 | 2023-07-18 | $30.04 | $3.0M | -12.2% | -12.6% | -28.1% |
| ACAD | SELL · 10b5-1 | 2023-07-11 | 2023-07-13 | $25.04 | $3.2M | -1.6% | -6.9% | -22.2% |
| ACAD | SELL | 2023-05-01 | 2023-05-02 | $21.18 | $331K | +0.0% | +11.4% | +36.3% |
| ACAD | SELL | 2023-04-06 | 2023-04-07 | $18.16 | $312K | +10.4% | +18.8% | +33.6% |
| ACAD | SELL | 2023-02-24 | 2023-02-27 | $18.78 | $145K | +3.3% | -4.4% | +19.8% |
| ACAD | SELL | 2023-01-09 | 2023-01-10 | $17.13 | $134K | +10.9% | +11.1% | +3.4% |
| ACAD | SELL | 2022-10-15 | 2022-10-18 | $15.81 | $44K | +3.1% | -4.3% | +15.3% |
| ACAD | SELL | 2022-05-02 | 2022-05-03 | $18.18 | $199K | -15.5% | -18.7% | -29.3% |
| ACAD | SELL | 2022-02-23 | 2022-02-25 | $23.80 | $187K | +1.3% | -3.2% | -36.3% |
| ACAD | SELL | 2022-01-06 | 2022-01-10 | $23.05 | $171K | -6.5% | +18.5% | +4.3% |
| ACAD | SELL | 2021-10-18 | 2021-10-19 | $17.41 | $103K | +1.6% | +7.3% | +18.6% |
| ACAD | SELL | 2021-04-30 | 2021-04-30 | $20.33 | $319K | +6.3% | +8.8% | +8.5% |
| ACAD | SELL | 2021-02-04 | 2021-02-08 | $50.61 | $1.4M | +1.3% | -47.3% | -58.8% |
| ACAD | SELL | 2021-01-06 | 2021-01-08 | $53.34 | $372K | -2.2% | -3.6% | -61.1% |
| ACAD | SELL | 2020-10-16 | 2020-10-19 | $42.56 | $252K | +14.1% | +29.7% | +28.6% |
| ACAD | SELL | 2020-05-13 | 2020-05-15 | $45.99 | $18.2M | -1.5% | -9.6% | -22.4% |
| ACAD | SELL | 2020-04-30 | 2020-05-01 | $49.21 | $666K | +3.4% | +9.8% | -4.6% |
| ACAD | SELL | 2019-12-05 | 2019-12-06 | $52.34 | $7.9M | -15.0% | -16.3% | -13.2% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.